CS
ABBV icon

Crescent Sterling’s AbbVie ABBV Stock Holding History

Crescent Sterling’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Buy
15,059
+158
+1% +$34K 3.39% 7
2026
Q1 		$3.24M Buy
14,901
+50
+0.3% +$11.1K 3.14% 8
2025
Q4 		$3.39M Sell
14,851
-660
-4% -$150K 3.48% 7
2025
Q3 		$3.59M Sell
15,511
-125
-0.8% -$25.5K 3.78% 6
2025
Q2 		$2.9M Sell
15,636
-1,945
-11% -$361K 3.25% 10
2025
Q1 		$3.68M Sell
17,581
-2,111
-11% -$410K 3.78% 7
2024
Q4 		$3.5M Sell
19,692
-830
-4% -$153K 3.59% 7
2024
Q3 		$4.05M Sell
20,522
-724
-3% -$135K 3.86% 4
2024
Q2 		$3.64M Sell
21,246
-418
-2% -$69.2K 3.49% 7
2024
Q1 		$3.95M Sell
21,664
-365
-2% -$62.9K 3.6% 7
2023
Q4 		$3.41M Sell
22,029
-37
-0.2% -$5.39K 3.41% 9
2023
Q3 		$3.29M Sell
22,066
-965
-4% -$142K 3.48% 8
2023
Q2 		$3.1M Buy
23,031
+89
+0.4% +$13.1K 2.94% 10
2023
Q1 		$3.66M Buy
22,942
+1,371
+6% +$210K 3.55% 9
2022
Q4 		$3.49M Buy
+21,571
New +$3.31M 3.74% 9

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Crescent Sterling's ABBV Position: Q2 2026 in Review

Crescent Sterling increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $34K and bringing the position to 15,059 shares worth $3.79M. The position accounts for 3.39% of the portfolio, ranked #7.

Crescent Sterling first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.05M in Q3 2024. 1,264 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crescent Sterling held 15,059 shares of AbbVie worth $3.79M as of Q2 2026.
  • Crescent Sterling bought 158 AbbVie shares in Q2 2026, an estimated $34K.
  • AbbVie made up 3.39% of Crescent Sterling's portfolio in Q2 2026, its #7 holding.
  • Crescent Sterling first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Crescent Sterling's AbbVie position peaked at $4.05M in Q3 2024.
  • 1,264 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.